Showing results (161-170 of 418) with videos related to

Sort By:
Pageof 42
Plos One|May 7, 2013
Prevalence of self-reported pain, joint complaints and knee or hip complaints in adults aged ≥ 40 years: a cross-sectional survey in Herne, GermanyUlrich Thiem, Rainer Lamsfuß, Sven Günther, et al.
Annals of the Rheumatic Diseases|June 25, 2016
Adalimumab long-term safety: infections, vaccination response and pregnancy outcomes in patients with rheumatoid arthritisGerd R Burmester, Robert Landewé, Mark C Genovese, et al.
Arthritis Care & Research|September 5, 2014
Tofacitinib with methotrexate in third-line treatment of patients with active rheumatoid arthritis: patient-reported outcomes from a phase III trialVibeke Strand, Gerd R Burmester, Cristiano A F Zerbini, et al.
Arthritis and Rheumatism|August 1, 2007
Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritisHolger Bang, Karl Egerer, Anke Gauliard, et al.
BMC Genomics|March 7, 2009
SiPaGene: A new repository for instant online retrieval, sharing and meta-analyses of GeneChip expression dataAdriane Menssen, Götz Edinger, Joachim R Grün, et al.
Rheumatology (Oxford, England)|May 29, 2009
Tenosynovitis of the flexor tendons of the hand detected by MRI: an early indicator of rheumatoid arthritisIris Eshed, Eugen Feist, Christian E Althoff, et al.
Trials|October 29, 2014
Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands (OA TREAT): study protocol for a randomized controlled trialJacqueline Detert, Pascal Klaus, Joachim Listing, et al.
The Journal of Rheumatology|April 15, 2024
Upadacitinib in Rheumatoid Arthritis and Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs: Efficacy and Safety Through 5 Years (SELECT-NEXT)Gerd R Burmester, Filip Van den Bosch, John Tesser, et al.
The Journal of Rheumatology|October 11, 2002
Circulating proteasomes are markers of cell damage and immunologic activity in autoimmune diseasesKarl Egerer, Ulrike Kuckelkorn, Paul E Rudolph, et al.
RMD Open|April 19, 2019
Re-treatment with abatacept plus methotrexate for disease flare after complete treatment withdrawal in patients with early rheumatoid arthritis: 2-year results from the AVERT studyPaul Emery, Gerd R Burmester, Vivian P Bykerk, et al.
Pageof 42